BeyondSpring Inc. (BYSI) Executive Compensation
BeyondSpring Inc. (BYSI) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BYSI
CIK: 1677940
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerYi-Hung Ouyang
Audit LocationCosta Mesa, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-13 | 2026-10-13 | FORM 8-K | 0001171843-26-006600 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-09-30 | FORM 8-K | 0001171843-26-006465 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-09-29 | FORM 8-K | 0001171843-26-006371 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | FORM 8-K | 0001171843-26-006273 | View SEC Doc Filr Page |
| 424B5 | 2026-09-29 | — | 424B5 | 0001140361-26-037918 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-17 | FORM 8-K | 0001171843-26-006116 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-03 | — | FORM DEFA14A | 0001171843-26-005880 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-03 | 2026-10-13 | DEFINITIVE PROXY STATEMENT | 0001171843-26-005879 | View SEC Doc Filr Page |
| ARS | 2026-09-03 | 2025-12-31 | ARS | 0001171843-26-005877 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001140361-26-033219 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001171843-26-005558 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | FORM 8-K | 0001171843-26-005557 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-295935 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-295934 | View SEC Doc Filr Page |
| 3 | 2026-07-06 | 2026-07-01 | 3 | 0001193125-26-295932 | View SEC Doc Filr Page |
| 3 | 2026-07-06 | 2026-07-01 | 3 | 0001193125-26-295930 | View SEC Doc Filr Page |
| 8-K/A | 2026-06-29 | 2026-06-04 | FORM 8-K/A | 0001171843-26-004354 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-04 | FORM 8-K | 0001171843-26-003908 | View SEC Doc Filr Page |
| 4 | 2026-05-15 | 2026-03-20 | 4 | 0001193125-26-226749 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001140361-26-021645 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | FORM 10-Q | 0001171843-26-003372 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | FORM 8-K | 0001171843-26-003344 | View SEC Doc Filr Page |
| 4 | 2026-04-08 | 2026-04-01 | 4 | 0001193125-26-147830 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-01 | 4 | 0001193125-26-142402 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-01 | 4 | 0001193125-26-142218 | View SEC Doc Filr Page |